Axa’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-9,400
Closed -$471K 1202
2021
Q3
$471K Hold
9,400
﹤0.01% 1069
2021
Q2
$592K Hold
9,400
﹤0.01% 1074
2021
Q1
$873K Hold
9,400
﹤0.01% 994
2020
Q4
$842K Hold
9,400
﹤0.01% 994
2020
Q3
$971K Buy
+9,400
New +$971K ﹤0.01% 939
2020
Q2
Sell
-5,100
Closed -$295K 1247
2020
Q1
$295K Buy
+5,100
New +$295K ﹤0.01% 1048
2018
Q4
Sell
-6,400
Closed -$421K 1317
2018
Q3
$421K Sell
6,400
-7,200
-53% -$474K ﹤0.01% 1173
2018
Q2
$687K Hold
13,600
﹤0.01% 1086
2018
Q1
$716K Sell
13,600
-12,600
-48% -$663K ﹤0.01% 1078
2017
Q4
$1.22M Sell
26,200
-90,900
-78% -$4.23M ﹤0.01% 954
2017
Q3
$4.74M Buy
117,100
+109,900
+1,526% +$4.45M 0.02% 641
2017
Q2
$244K Hold
7,200
﹤0.01% 1177
2017
Q1
$209K Sell
7,200
-6,535
-48% -$190K ﹤0.01% 1217
2016
Q4
$451K Sell
13,735
-72,065
-84% -$2.37M ﹤0.01% 1069
2016
Q3
$2.71M Buy
85,800
+27,800
+48% +$876K 0.01% 690
2016
Q2
$1.63M Sell
58,000
-28,100
-33% -$790K 0.01% 775
2016
Q1
$3.13M Sell
86,100
-11,800
-12% -$429K 0.01% 667
2015
Q4
$3.92M Sell
97,900
-300
-0.3% -$12K 0.02% 621
2015
Q3
$2.8M Buy
98,200
+7,200
+8% +$205K 0.01% 706
2015
Q2
$3M Sell
91,000
-92,000
-50% -$3.03M 0.01% 705
2015
Q1
$5.26M Buy
183,000
+15,744
+9% +$453K 0.02% 590
2014
Q4
$4.55M Buy
167,256
+117,256
+235% +$3.19M 0.02% 580
2014
Q3
$1.07M Buy
50,000
+5,500
+12% +$117K ﹤0.01% 892
2014
Q2
$999K Buy
44,500
+1,100
+3% +$24.7K ﹤0.01% 925
2014
Q1
$1.1M Sell
43,400
-5,200
-11% -$131K ﹤0.01% 903
2013
Q4
$1.12M Sell
48,600
-2,873
-6% -$66K 0.01% 902
2013
Q3
$981K Buy
51,473
+3,173
+7% +$60.5K ﹤0.01% 874
2013
Q2
$696K Buy
+48,300
New +$696K ﹤0.01% 901